Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial exploring allogeneic hematopoietic stem cell transplantation for patients with inborn errors of immunity is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Lymphoproliferative Syndrome
• Common Variable Immunodeficiency
• Lymphoproliferative Disorders
• T-cell Immunodeficiency Disorders

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative | Phase 2 | Status: RECRUITING